Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Brain Res. 2020 Dec 23;1752:147222. doi: 10.1016/j.brainres.2020.147222

Figure 1.

Figure 1.

The efficacy of Entinostat in inhibiting the deacetylase activity of recombinant human class I HDACs 1, 2, and 3 was determined and the IC50 values were calculated using GraphPad.